Mitchell D. Schnall
Mitchell Schnall is the radiologist who brought imaging research into the ECOG-ACRIN cooperative group.
Radiologist and former ACRIN network chair who co-chairs ECOG-ACRIN. Led multicentre trials of breast MRI and imaging biomarkers, including the TMIST tomosynthesis screening trial.
| Title | Journal | Year |
|---|---|---|
| MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer | New England Journal of Medicine | 2007 |
| Diagnostic architectural and dynamic features at breast MR imaging: multicenter study | Radiology | 2006 |
Pages like this
not linked directly; found by shared links- PersonPeter J. O'Dwyer
Shares ECOG-ACRIN Cancer Research Group, Abramson Cancer Center, University of Pennsylvania.
- PersonAngela DeMichele
Shares Abramson Cancer Center, University of Pennsylvania, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- TechnologyMirai (MIT breast cancer risk from mammograms)
Shares Mammography & tomosynthesis, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- IdeaOne-stop breast clinics: imaging, biopsy and a preliminary answer in a single visit
Shares Mammography & tomosynthesis, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- IdeaAfter the COMET trial: surveillance pathways and a new name for low-risk DCIS
Shares Mammography & tomosynthesis, HR-positive / HER2-negative breast cancer.
- CollectionSusan G. Komen
Shares Mammography & tomosynthesis, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- IdeaSet each woman's mammogram interval from her last mammogram, using AI risk
Shares Mammography & tomosynthesis, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
- PersonLaura J. Esserman
Shares Mammography & tomosynthesis, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.